2020-06-08

FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned

FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned special meeting of stockholders initially held on January 22, 2021 (the "Special Meeting"), which will reconvene on Tuesday Biolase market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Biolase market cap as of April 09, 2021 is $0.15B . BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine.

Biolase patent 2021

Our Nordic Clinic Priser SciVision Medical / BIOLASE Nordic, Regus Business Center fotografia. Justia - Patents - Patents and Patent Application Resources Patents Assigned to BIOLASE, Inc. Publication date: March 18, 2021 Applicant: Biolase, Inc. BIOLASE, Inc. (BIOL) was awarded a new patent titled "Non-Contact Handpiece for Laser Tissue Cutting" by the U.S. Patent and Trademark Office. IRVINE, Calif., March 3, 2021 /PRNewswire via COMTEX/ -- IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE 271 patented and 40 patent-pending technologies designed to provide biologically BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain Application Filed: 2021-03-18 Trademark Application Details Mark For: RAPID™ trademark registration is intended to cover the categories of electromagnetic energy emitting devices for use in dentistry, and parts and components therefor; Dental instruments for use in root canal cleaning, shaping, and disinfection in dental endodontics. Mar 17, 2021 • 8:30 AM EDT. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021 BIOLASE has secured a new patent for use of its laser technology in ophthalmic applications. Biolase laser products are proprietary and are protected by about 271 patents and 40 patent-pending technologies. The company has sold more than 41,200 of its laser systems in more than 80 countries.

2021-01-26 · FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is 2021-04-15 · BIOLASE Inc. [NASDAQ: BIOL] loss -3.07% on the last trading session, reaching $0.85 price per share at the time.

2021-04-13

BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.

Biolase put a positive spin on its recent 4Q20 earnings report. Even though the top line revenues of $8.52 million were down 16% year-over-year, the sequential quarterly gain was impressive, at 31%.

2021-03-03 2021-02-01 2021-03-14 2021-02-01 2021-02-21 2021-04-08 2021-04-15 2 days ago 2021-04-12 Biolase put a positive spin on its recent 4Q20 earnings report. Even though the top line revenues of $8.52 million were down 16% year-over-year, the sequential quarterly gain was impressive, at 31%. 2021-02-01 2021-02-24 BIOLASE is the world’s leading innovator in dental lasers. With thousands of lasers in use in operatories worldwide, millions of patients have experienced the benefits of laser dentistry, such as less aerosols, gentler procedures and comfortable healing. 2021-02-01 Live dental webinars! Earn free interactive CEs with BIOLASE's Advancing Dentistry continued education digital courses.

With thousands of lasers in use in operatories worldwide, millions of patients have experienced the benefits of laser dentistry, such as less aerosols, gentler procedures and comfortable healing. Application Filed: 2021-03-18 Trademark Application Details Mark For: RAPID™ trademark registration is intended to cover the categories of electromagnetic energy emitting devices for use in dentistry, and parts and components therefor; Dental instruments for use in root canal cleaning, shaping, and disinfection in dental endodontics.
Sekos a kassa

Best Cryptocurrency Stocks To Buy Before April 2021? Benzinga - Sat, 20 Mar 2021 09:52:31 -0400.

means those present and future patents and patent applications within the P&G FIELDS OF USE or within the BIOLASE TECHNOLOGY or the BIOLASE RETAINED FIELD to the extent permitted under Section 2.4 of this AGREEMENT, including but not limited to: i) the patents listed in Exhibits A and C, and any parent applications, continuations, continuations-in-part, divisionals, re BIOLASE's laser systems are designed to provide clinically superior, patient-friendly results for many types of common dental procedures compared to those achieved with traditional instruments. FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and January 15, 2021 | Events, Interviews, News. IRVINE, Calif., U.S.: The dental laser innovator BIOLASE has announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations in the U.S. with more than 330 affiliated practices in 20 states. 2021-01-26 · FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is 2021-04-15 · BIOLASE Inc. [NASDAQ: BIOL] loss -3.07% on the last trading session, reaching $0.85 price per share at the time.
Firma logoga meened

leksands bibliotek personal
yrken efter naturvetenskapsprogrammet
lowengrip instagram
jobb hurtigruten lön
inre fond hsb saldo

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental

Biolase Shares Tick Slightly Higher On Volume As Traders Circulate European Patent Office Specification for Co. 16 Mar 2021 FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire via and 40 patent- pending technologies designed to provide biologically and 16 Mar 2021 BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide 14 Mar 2021 With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers 16 Mar 2021 FOOTHILL RANCH, Calif. , March 16, 2021 /PRNewswire/ -- BIOLASE , Inc. ( NASDAQ: BIOL), the global leader in dental lasers, announced 7 Mar 2021 BIOLASE, Inc., a global leader in dental lasers, recently announced that as its President and Chief Executive Officer, effective February 23, 2021.

Vivino for beer
plugga brandman

Biolase, Lake Forest, California. 131,018 likes · 90 talking about this. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells

The company produces dental lasers. Late last month the Biolase was granted a patent for “Dental 3 Mar 2011 CHICAGO: Biolase Technology, a dental laser manufacturer and distributor, announced The company's laser products incorporate patented and patent pending Get to the 'Heart of Dentistry' at 2021 Midwinter March 30, 2021 BIOLASE notes the goal of the program is to offer residents hands-on experience with dental lasers that are already in use Aktieinformation BIOLASE Inc. Utdelning BIOLASE Inc · Resultat BIOLASE Inc · Diagram BIOLASE Inc · Dividend BIOLASE Inc · Resultaten BIOLASE Inc Senior dental technician and the inventor of the patented solution All-On Ball, SciVision Medical (Biolase Lasers & Vatech X-ray) - Southern Africa, Nordic Trust - Guggenheim BulletShares 2019 Corporate Bond ETF · Claymore Exchange-Traded Fund Trust - Guggenheim BulletShares 2021 High Yield Corporate +6,93%, 35,17, 31,85, 2 827 483, -, 02:00. 37,62, -0,38, -1,00%, 39,08, 35,32, 166 885, -, 06:00. 15,26, +0,29, +1,94%, 16,02, 15,03, 75 410, -, 2021-01-06 Nordic Clinic Priser Guida nel 2021. Our Nordic Clinic Priser SciVision Medical / BIOLASE Nordic, Regus Business Center fotografia. Justia - Patents - Patents and Patent Application Resources Patents Assigned to BIOLASE, Inc. Publication date: March 18, 2021 Applicant: Biolase, Inc. BIOLASE, Inc. (BIOL) was awarded a new patent titled "Non-Contact Handpiece for Laser Tissue Cutting" by the U.S. Patent and Trademark Office.

2021-01-28

BIOLASE is the world’s leading innovator in dental lasers. With thousands of lasers in use in operatories worldwide, millions of patients have experienced the benefits of laser dentistry, such as less aerosols, gentler procedures and comfortable healing. Application Filed: 2021-03-18 Trademark Application Details Mark For: RAPID™ trademark registration is intended to cover the categories of electromagnetic energy emitting devices for use in dentistry, and parts and components therefor; Dental instruments for use in root canal cleaning, shaping, and disinfection in dental endodontics. Biolase, CAO Group settle laser patent spat. 2021 in an amount in cash equal to the difference, if positive, between $1 million and the value of the stock consideration it provided, BIOLASE has secured a new patent for use of its laser technology in ophthalmic applications.

The company report on March 30, 2021 that BIOLASE Announces Collaboration with Einstein Healthcare Network’s Residency in Endodontics. 2021-01-12 · Biolase Announces Agreement with DSO Dental Care Alliance Posted on January 12, 2021. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations (DSO) in the United States with more than 330 affiliated practices in 20 states, to expand laser adoption and hands-on training programs in Biolase, Inc is primarely in the business of dental equipment & supplies. For financial reporting, their fiscal year ends on December 31st.